Returning guest, Dr. Jacqueline A. Nicholas, MD, MPH, discusses multiple sclerosis (MS) and MS relapses. She talks about the recently FDA approved ZEPOSIA® (ozanimod) a new oral therapy to treat appropriate adult patients with relapsing forms of MS and other complications.
Dr. Nicholas is a board-certified clinical neuroimmunologist specializing in multiple sclerosis (MS) and spasticity. Dr. Nicholas received her undergraduate degree from Miami University in Oxford, Ohio, and her medical degree from the University of Toledo College of Medicine in Toledo, Ohio. She trained at the University of Pittsburgh Medical Center where she completed an internship in internal medicine and a neurology residency where she served as chief neurology resident. Dr. Nicholas completed a fellowship in clinical neuroimmunology, multiple sclerosis and spasticity at The Ohio State University Medical Center in Columbus, Ohio while also completing her Master of Public Health at The Ohio State University College of Public Health. She previously served on faculty at The Ohio State University Medical Center. She has worked for OhioHealth Riverside Methodist Hospital in Columbus, Ohio for over 5 years, where she serves as System Chief of Neuroimmunology & Multiple Sclerosis, Director of MS Research and Neuroimmunology Fellowship Director at the OhioHealth Multiple Sclerosis Center. She is an Adjunct Clinical Assistant Professor of Neurology for University of Toledo College of Medicine and Ohio University College of Medicine.